July 12, 2017 Nektar Therapeutcs Presents New Preclinical Data for First-In-Class Regulatory T Cell Stimulator July 12, 2017 Nektar Therapeutics recently announced positive preclinical results for NKTR-358, a first-in-class resolution therapeutic for autoimmune disease. The new preclinical data...